|
Cash Flow for
Omrix Biopharmaceuticals Inc.
(OMRI)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
11,940 |
(27,712) |
(6,604) |
| Depreciation |
1,009 |
762 |
659 |
| Amortization |
- |
148 |
96 |
| Amortization of Intagibles |
272 |
29 |
- |
| Deferred Income Taxes |
- |
- |
- |
| Operating Gains/Losses |
- |
24,685 |
1,225 |
| Extraordinary Gains/Losses |
- |
- |
- |
| Decrease in Receivables |
(13,235) |
171 |
(738) |
| Decrease in Inventories |
(2,248) |
(53) |
1,495 |
| Decrease in Prepaid Expenses |
(157) |
542 |
(228) |
| Decrease in Other Current Assets |
- |
- |
- |
| Increase in Payables |
(429) |
(2,262) |
47 |
| Increase in Other Current Liabilities |
1,083 |
277 |
6,429 |
| Decrease in Other Working Capital |
1,014 |
- |
- |
| Other Non-Cash Items |
(48) |
- |
- |
| Net Cash from Continuing Operations |
(799) |
(3,413) |
2,381 |
| Net Cash from Discontinued Operations |
- |
- |
- |
| Cash from Operating Activities |
(799) |
(3,413) |
2,381 |
|
|
| Sale of Property, Plant, Equipment |
- |
3 |
11 |
| Sale of Long Term Investments |
2,198 |
279 |
- |
| Sale of Short Term Investments |
67,031 |
- |
- |
| Purchase of Property, Plant, Equipment |
(7,170) |
(973) |
(2,661) |
| Acquisitions |
- |
- |
- |
| Purchase of Long Term Investments |
(846) |
- |
(3) |
| Purchase of Short Term Investments |
(87,045) |
- |
- |
| Other Investment Changes, Net |
- |
(585) |
- |
| Cash from Investing Activities |
(25,832) |
(1,276) |
(2,653) |
| Cash from Discontinued Investing Activities |
- |
- |
- |
|
| Issuance of Debt |
- |
7,229 |
1,910 |
| Issuance of Capital Stock |
8,375 |
- |
4,892 |
| Repayment of Debt |
(1,221) |
(1,024) |
(2,809) |
| Repurchase of Capital Stock |
- |
- |
- |
| Payment of Cash Dividends |
- |
- |
- |
| Other Financing Charges, Net |
(788) |
(579) |
- |
| Cash from Financing Activities |
6,366 |
5,626 |
3,993 |
| Cash from Discontinued Financing Activities |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
258 |
68 |
(45) |
| Net Change in Cash |
(20,007) |
1,005 |
3,676 |
|
| Cash at Beginning of Year |
45,892 |
5,489 |
1,813 |
| Cash at End of Period |
25,885 |
6,494 |
5,489 |
| Foreign Sales |
37,228 |
17,954 |
15,801 |
| Domestic Sales |
24,477 |
9,545 |
4,147 |
|
|
|
